Schneider National, Inc. Class B SNDR 深 滬
交易中 07-17 10:05:41 美东时间
25.51
+0.360
+1.43%
華盛通- 最 高25.51
- 今 開25.07
- 成交量 1.58万股
- 最 低 25.07
- 昨 收 25.15
- 總市值 44.64亿
- 52周最高 33.615
- 市盈率 靜 38.40
- 換手率 0.01%
- 52周最低 20.495
- 委 比 -76.99%
- 總股本 1.75亿
- 歷史最高 33.615
- 量 比 0.29
- 振 幅 1.75%
- 歷史最低 11.635
- 每 手 1
- 風險率 2.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅107.37%！花旗上调ProKidney目标价至9美元，维持"买入"评级
今日重点评级关注：花旗：维持ProKidney Corp. - Class A Ordinary Shares"买入"评级，目标价从6美元升至9美元；Canaccord Genuity：维持e.l.f. Beauty"买入"评级，目标价从114美元升至150美元
07-10 09:55
Citigroup Maintains Neutral on Schneider National, Raises Price Target to $27
Citigroup analyst Ariel Rosa maintains Schneider National (NYSE:SNDR) with a Neutral and raises the price target from $24 to $27.
07-10 02:50
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Baird Reinstates Outperform on Schneider National, Announces $28 Price Target
Baird analyst Daniel Moore reinstates Schneider National (NYSE:SNDR) with a Outperform and announces $28 price target.
07-01 21:28
The European Commission extends benefits for zero-emission heavy-duty vehicles
The European Commission proposed on Friday to exempt zero-emission heavy-duty vehicles from road tolls until 2031. The agency said it is taking the action to stimulate and support the competitiveness ...
06-27 18:51
美股大行评级 | 再生元制药遭大摩下调评级，Aspen Insurance Hldgs(AHL)获多家机构首予“超配”评级！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136585934532136961.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Vera Therapeutics(VERA)"买入"评级，目标价从75美元升至85美元</p> <p>• Ascendiant Capital：维持60 Degrees
06-03 09:06
Goldman Sachs Upgrades Schneider National to Buy, Raises Price Target to $32
Goldman Sachs analyst Jordan Alliger upgrades Schneider National (NYSE:SNDR) from Neutral to Buy and raises the price target from $24 to $32.
06-02 18:22
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
B of A Securities Maintains Neutral on Schneider National, Raises Price Target to $26
B of A Securities analyst Ken Hoexter maintains Schneider National (NYSE:SNDR) with a Neutral and raises the price target from $23 to $26.
05-16 23:05
What to Expect from Landstar System's Earnings
Landstar System (NASDAQ:LSTR) is preparing to release its quarterly earnings on...
05-12 22:02
